Zoom shares surge premarket after video conferencing group tops Q4 estimates

-- Zoom Video Communications (NASDAQ:ZM) has reported fourth-quarter results that beat Wall Street estimates thanks to solid demand for its products during a time of increased hybrid working habits.   Shares in the video-conferencing software provider (NASDAQ:ZM), which also unveiled plans to buy back up to $1.5 billion of its Class A common stock, rose sharply in...

Read More

China approves Everest and Kezar lupus drug trial

SHANGHAI, China - Everest Medicines and Kezar Life Sciences (NASDAQ:KZR), Inc. have received approval from the Center for Drug Evaluation (CDE) of China\'s National Medical Products Administration (NMPA) to initiate a Phase 2b clinical trial for zetomipzomib, a treatment for lupus nephritis (LN), in China. The trial, named PALIZADE, will assess the efficacy and safety...

Read More

Walt Disney Studios names Greenbaum as president

By Dawn Chmielewski and Lisa Richwine (Reuters) - David Greenbaum has been named to the newly created role of president, overseeing Disney Live Action and 20th Century studios, reporting to Disney Entertainment co-Chairman Alan Bergman, Walt Disney (NYSE:DIS) Studios announced on Monday. He succeeds Sean Bailey, who oversaw Disney\'s live action films since 2010, and...

Read More